‹ All stocks
Indivior Pharmaceuticals Inc
INDV · NASDAQ · Healthcare
$35.47
▲ $35.47 (0.03%)
Day range
$35.37 – $36.15
Year range
$22.56 – $42.81
Open
$35.46
Previous close
—
Market cap
$4.43B
Volume (24h)
$398.5K
Volume (52w)
$14.13M
Performance
7D
▼ -3.82%
1M
▲ 1.20%
3M
▼ -11.30%
6M
▲ 16.60%
1Y
▲ 52.49%
YTD
▼ -0.73%
3Y
▲ 70.69%
5Y
▲ 143.78%
All-time
▲ 233.05%
Key statistics
P/E ratio
9.72
EPS (TTM)
$3.65
Dividend yield
—
Dividend (TTM)
—
Payout ratio
—
Shares outstanding
124.8M
About Indivior Pharmaceuticals Inc
Indivior Pharmaceuticals Inc. operates as a holding company, primarily engaged in the research, production, and distribution of buprenorphine-based prescription medications designed to treat opioid dependence. Its product lineup features key pharmaceuticals such as Suboxone Film, Suboxone Tablet, and Subutex Tablet. The company organizes its business into several geographical regions: the United States, the United Kingdom, and the broader international market. Established on September 26, 2014, its corporate headquarters are located in North Chesterfield, Virginia.
Visit websiteCountry: United States of America
More in Healthcare
LLY Eli Lilly and Company |
$1139.65 | -1.23% |
JNJ Johnson & Johnson |
$256.11 | -1.42% |
ABBV AbbVie |
$260.91 | 0.45% |
MRK Merck & Co. |
$143.38 | -0.27% |
UNH UnitedHealth Group Incorp… |
$368.09 | 0.81% |